02/22/2011 - 3:41pm

A new Harris Poll published Tuesday suggested that many doctors are doing little or nothing to help their overweight patients to lose weight.

02/18/2011 - 5:02pm

The news that CVS Caremark's Pharmacy Advisor program has been recognized by the Pharmacy Benefit Management Institute is yet one more illustration of how the company has positioned itself along the front lines to leverage its various points of care to improve outcomes and lower healthcare costs.

02/18/2011 - 4:35pm

As one retail pharmacy executive put it, "many members of Congress only experience the pharmacy industry through their eyes as a patient." Thanks to NACDS RxImpact Day on Capitol Hill, however, that no longer has to be the case.

02/18/2011 - 3:56pm

Nearly 39 million people are feeling the effects of cold and flu as illness levels continue to climb across the nation, Boiron reported Friday.

02/18/2011 - 3:41pm

If an ounce of prevention is worth a pound of cure, then that means 200 sq. ft. of retail pharmacy is the equivalent to acres of doctors' offices and medical clinics. If inhibitive cost, lack of awareness and prohibitive access represent the reasons behind why more people don’t get vaccinated, then pharmacy provides the all-in-one solution — because pharmacy can help eclipse each one of those vaccine barriers.

02/18/2011 - 11:44am

A drug used to treat high cholesterol, which will lose patent protection and face generic competition starting this year, also may help prevent blindness in people with diabetes, according to a study by researchers at the University of Georgia.

02/17/2011 - 11:48am

Kellogg's is emphasizing its fiber-rich cereals, following the release of a study that examined the link between dietary fiber from grains and the lower risk of death from certain diseases in both men and women.

02/17/2011 - 8:35am

While some ethnic cuisines have become mainstream, such as Italian and Chinese food, some lesser-known ethnic food products are enjoying growth in the marketplace, according to new research by Mintel.

02/16/2011 - 12:55pm

Amicus Therapeutics received good results from its mid-stage trial of a drug for a rare, genetic disorder, the drug maker said Wednesday.